1. Home
  2. LSBK vs QNCX Comparison

LSBK vs QNCX Comparison

Compare LSBK & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBK
  • QNCX
  • Stock Information
  • Founded
  • LSBK 1891
  • QNCX 2012
  • Country
  • LSBK United States
  • QNCX United States
  • Employees
  • LSBK N/A
  • QNCX N/A
  • Industry
  • LSBK Savings Institutions
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LSBK Finance
  • QNCX Health Care
  • Exchange
  • LSBK Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • LSBK 91.1M
  • QNCX 62.0M
  • IPO Year
  • LSBK 2006
  • QNCX 2019
  • Fundamental
  • Price
  • LSBK $16.18
  • QNCX $1.42
  • Analyst Decision
  • LSBK
  • QNCX Strong Buy
  • Analyst Count
  • LSBK 0
  • QNCX 4
  • Target Price
  • LSBK N/A
  • QNCX $9.50
  • AVG Volume (30 Days)
  • LSBK 3.4K
  • QNCX 124.3K
  • Earning Date
  • LSBK 01-24-2025
  • QNCX 03-31-2025
  • Dividend Yield
  • LSBK 3.38%
  • QNCX N/A
  • EPS Growth
  • LSBK 7.32
  • QNCX N/A
  • EPS
  • LSBK 0.88
  • QNCX N/A
  • Revenue
  • LSBK $25,846,000.00
  • QNCX N/A
  • Revenue This Year
  • LSBK N/A
  • QNCX N/A
  • Revenue Next Year
  • LSBK N/A
  • QNCX N/A
  • P/E Ratio
  • LSBK $17.98
  • QNCX N/A
  • Revenue Growth
  • LSBK N/A
  • QNCX N/A
  • 52 Week Low
  • LSBK $10.30
  • QNCX $0.51
  • 52 Week High
  • LSBK $16.56
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • LSBK 71.76
  • QNCX 37.52
  • Support Level
  • LSBK $15.45
  • QNCX $1.37
  • Resistance Level
  • LSBK $15.78
  • QNCX $1.69
  • Average True Range (ATR)
  • LSBK 0.40
  • QNCX 0.12
  • MACD
  • LSBK 0.12
  • QNCX -0.02
  • Stochastic Oscillator
  • LSBK 87.81
  • QNCX 12.20

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: